The effect of trehalose on Fatigue in MS
Not Applicable
Not yet recruiting
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20181022041407N8
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Suffering from multiple sclerosis (MS)
At least 6 months under treatment
Age more than 18
Suffering from fatigue
EDSS less or equal to 6
Satisfaction for participation in the research project
Ability to read
Exclusion Criteria
Under treatment for depression
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie trehalose's effect on fatigue in multiple sclerosis patients?
How does trehalose compare to standard-of-care treatments for MS-related fatigue in clinical trials?
Are there specific biomarkers that predict MS patient response to trehalose therapy?
What are the potential adverse events associated with trehalose administration in MS patients?
What related compounds or combination therapies show promise in managing MS fatigue alongside trehalose?